• July 16, 2019

VentureClash is Connecticut’s $5 million global venture challenge focused on promising and high-growth companies. Managed by Connecticut Innovations, VentureClash scans the globe for disruptive fintech, insurtech, industry 4.0 and digital health companies that are looking to land and expand in Connecticut. The first-round application launches in February and after two rounds of outside judging, approximately 10 finalists pitch every October at Yale University for an opportunity to secure a $1.5 million investment.

What is VentureClash?

VentureClash is Connecticut’s global venture challenge for early-stage digital health and fintech companies. In addition to company investments, VentureClash awardees also benefit from introductions to a critical network of potential customers, investors, mentors and talent.

Who runs VentureClash?

  • VentureClash is managed by Connecticut Innovations, the leading source of financing and ongoing support for Connecticut’s innovative, growing companies.
  • Connecticut Innovations provides venture capital, venture debt and strategic support for early-stage technology companies; grants that support innovation and collaboration; and connections to its well-established network of partners and professionals.
  • To view Connecticut Innovations’ portfolio of companies, visit For more information, visit

How do you define fintech?

Fintech refers to financial technology companies that leverage software in innovative ways to provide financial services. VentureClash takes a broad view of what constitutes fintech–a view that mirrors Connecticut’s diverse financial services industry. Our definition includes insurance, payments, lending, security, transfers, wealth management, distributed ledgers, big data analytics and more. If you think your company fits this definition, fill out the short application for a chance to compete.

How do you define digital health?

Digital health refers to technology companies that use software and data analytics to improve the delivery and outcomes of healthcare. It is fueled by rapid advances in medicine, genomics, mobile technology, and communications. VentureClash is interested in a wide range of digital health areas, including patient engagement, behavioral health, population health, telematics, telehealth, medication adherence, genomics, big data analytics and much more. Please fill out an application if your company has a technology that fits the description.

What does “early stage” mean?

Early-stage companies are beyond the idea stage. They have products and users, and are looking for capital to fund their expansion. To be eligible to compete in VentureClash, companies must have been in business for at least 12 months and have customers—either paying for its products or actively testing them.

More answers to your questions can be found here

Ready To Take the Next Step?

We assist our clients in locating, applying for, and evaluating the outcomes of non-dilutive grant funding. We believe non-dilutive funding is a crucial tool for mitigating investment risks, and we are dedicated to guiding our clients through the entire process—from identifying the most suitable opportunities to submitting and managing grant applications.